CompletedPhase 2

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

Italy40 participantsStarted 2013-07

Plain-language summary

The objective of this phase 2 study is to evaluate the feasibility of an early palliative care intervention for metastatic cancer patients. Feasibility will be assessed in terms of percentage of patients that accept the proposal of the early palliative care intervention and that effectively start to be followed in the palliative care out-patient clinic. The study will be performed in a consecutive series of newly diagnosed patients affected by lung cancer (NSCLC or SCLC, stage IIIb, IV), mesothelioma (stage II, IV), pancreas (stage IV), stomach (stage IIIb-IV).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients within 8 weeks of cancer diagnosis confirmed by histology or cytology * lung cancer (NSCLC or SCLC) stage IIIb-IV OR mesothelioma stage III-IV OR pancreas cancer stage IV, OR gastric cancer stage IIIb-IV * age more than 18 years * performance status (ECOG) ≤ 2; * ability to read, understand and fill-in the questionnaires * written informed consent to the study Exclusion Criteria: * any chemotherapy, radiotherapy or ormonotherapy for any tumour in the past 12 months

What they're measuring

percentage of cancer patients that accept and attend the early palliative care programme

Timeframe: up to 30 days after the diagnosis of cancer

Trial details

NCT IDNCT02078700

SponsorAzienda USL Reggio Emilia - IRCCS

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2014-04

View on ClinicalTrials.gov More Lung Cancer trials